SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
CytRx Corporation Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin (INNO-206) and Doxorubicin in Patients with Advanced Solid Tumors